insights_auto
Utsikter: 20.7 % optimistiske·13.8 % pessimistiske
Gå til analysenchevron_right
GH:NASDAQ
Guardant Health Inc
154,78 USD
0,00%
(0,00) 1 D
157,75 USD
arrow_upward
+1,92% (+2,97)todayFør børsåpning
Stengt: 11. nov., 16:00:01 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for GH …
Markedsverdi
20,94 mrd.
Snittvolum
2,08 mill.
Volum
53,72k
52 u høy
191,05 USD
52 u lav
74,55 USD
EPS
−3,68 USD
Beta
1,67
Utestående aksjer
135,29 mill.
Antall ansatte
2k
Markedsverdi
20,94 mrd.
Snittvolum
2,08 mill.
Volum
53,72k
52 u høy
191,05 USD
52 u lav
74,55 USD
EPS
−3,68 USD
Beta
1,67
Utestående aksjer
135,29 mill.
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Investing.com
·
for 7 timer siden
Guardant Health prices $500 million convertible notes offering
Investing.com
·
for 14 timer siden
Guardant Health director Steve Krognes sells $1.17M in shares
Investing.com
·
for 14 timer siden
Guardant Health director Tariq Musa sells $20,300 in stock
Investing.com
·
for 14 timer siden
Guardant Health director Alex Azar II sells $144,550 in stock
Profil
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
Om Guardant Health Inc
Administrerende direktørHelmy Eltoukhy | AmirAli Talasaz
Ansatte2,5k
Grunnlagt2012
HovedkontorPalo Alto, California, USA
SektorHealth Care
Bransje-
Nettstedguardanthealth.com